Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells

Genes Chromosomes and Cancer

Volumn 37, Issue 2, 2003, Pages 141-148

  Florl, Andrea R ^a   Schulz, Wolfgang A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P14;

ARTICLE; BLADDER CARCINOGENESIS; CANCER CELL; CDKN2A GENE; CHROMOSOME 9P; DNA REPAIR; DNA STRAND BREAKAGE; GENE; GENE DELETION; GENE LOCATION; GENE MAPPING; GENE STRUCTURE; GENETIC CODE; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; RETROPOSON; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; GENES, P16; HOMOZYGOTE; HUMANS; KIDNEY NEOPLASMS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MICROSATELLITE REPEATS; MOLECULAR SEQUENCE DATA; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0038746982     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10192     Document Type: Article

References (23)

1. Drechsler M, Royer-Pokora B. 1996. A LINE element is present at the site ofa 300-kb deletion starting in intron 10 of the PAX6 gene in a case of familial aniridia. Hum Genet 98:297-303.
2. Dreyling MH, Roulston D, Bohlander SK, Vardiman J, Olopade OI. 1998. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer 22:72-78.
3. Florl AR, Loewer R, Schmitz-Dräger BJ, Schulz WA. 1999. DNA methylation and expression of L1 LINE and HERV-K provirus sequences in urothelial and renal cell carcinoma. Br J Cancer 80:1312-1321.
4. Florl AR, Franke KH, Niederacher D, Gerharz CD, Seifert HH, Schulz WA. 2000. DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder. Lab Invest 80:1513-1522.
5. Gerharz CD, Moll R, Storkel S, Ramp U, Thoenes W, Gabbert HE. 1993. Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro. Am J Pathol 142:851-859.
6. Grimm MO, Jürgens B, Schulz WA, Decken K, Makri D, Schmitz-Dräger BJ. 1995. Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines. Urol Res 23:293-300.
7. Huang S. 2002. Histone methyltransferases, diet nutrients and tumour suppressors. Nat Rev Cancer 2:469-476.
8. Klugbauer S, Pfeiffer P, Gassenhuber H, Beimfohr C, Rabes HM. 2001. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes. Genomics 73:149-160.
9. Mimori K, Druck T, Inoue H, Alder H, Berk L, Mori M, Huebner K, Croce CM. 1999. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc Natl Acad Sci USA 96:7456-7461.
10. Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, Reuter VE, Zhang ZF, Beach D, Cordon-Cardo C. 1995. Deletion of the p16 and p15 genes in human bladder tumors. Cancer Res 54:2848-2851.
11. Ostertag EM, Kazazian HH Jr. 2001. Biology of mammalian L1 retrotransposons. Annu Rev Genet 35:501-538.
12. Oya M, Schmidt B, Schmitz-Dräger BJ, Schulz WA. 1998. Expression of G1→S transition regulatory molecules in human urothelial cancer. Jpn J Cancer Res 89:719-726.
13. Pfeiffer P, Goedecke W, Obe G. 2000. Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis 15:289-302.
14. Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M. 2001. Double-strand breaks and tumorigenesis. Trends Cell Biol 11:S52-S59.
15. Pomykala HM, Bohlander SK, Broeker PL, Olopade OI, Diaz MO. 1994. Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Mol Cell Biol 14:7604-7610.
16. Ruas M, Peters G. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochem Biophys Acta 1378:115-177.
17. Schmid M, Malicki D, Nobori T, Rosenbach MD, Campbell K, Carson DA, Carrera CJ. 1998. Homozygous deletions of methyl-thioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC). Oncogene 17:2669-2675.
18. Shaffer LG, Lupski JR. 2000. Molecular mechanisms for constitutional chromosomal rearrangements in humans. Annu Rev Genet 34:297-329.
19. Sowerby SJ, Kennedy MA, Fitzgerald PH, Morris CM. 1993. DNA sequence analysis of the major breakpoint cluster region of the BCR gene rearranged in Philadelphia-positive human leukemias. Oncogene 8:1679-1683.
20. Suminaga R, Takeshima Y, Yasuda K, Shiga K, Nakamura H, Matsuo M. 2000. Non-homologous recombination between Alu and LINE-1 repeats caused a 430-kb deletion in the dystrophin gene: a novel source of genomic instability. J Hum Genet 45:331-336.
21. Thandla SP, Ploski JE, Raza-Eglimez SZ, Chhalliyil PP, Block AMW, de Jong PJ, Aplan PD. 1999. ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene. Blood 93:293-299.
22. Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA. 1993. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4:1069-1577.
23. Yoder JA, Walsh CP, Bestor TH. 1997. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 13::335-340.